Among several tumors, overexpression of MATR3 has been associated with hepatocellular carcinoma (HCC) and non-small cell lung cancer (NSCLC) stageI/II development and has tumor-suppressive activity in basal-like breast cancer [38–40]. Here, MATR3 is linked to breast cancer.